http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#Head http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#provenance http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#pubinfo http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion http://purl.obolibrary.org/obo/DOID_14320 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_14320 http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00285 http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association http://www.w3.org/2000/01/rdf-schema#label venlafaxine hydrochloride extended release capsules usp are a serotonin and norepinephrine reuptake inhibitor snri indicated for the treatment of major depressive disorder mdd generalized anxiety disorder gad social anxiety disorder sad panic disorder pd venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of major depressive disorder mdd efficacy was established in three short term 4 8 and 12 weeks and two long term maintenance trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of generalized anxiety disorder gad efficacy was established in two 8 week and two 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of social anxiety disorder sad also known as social phobia efficacy was established in four 12 week and one 26 week placebo controlled trials venlafaxine hydrochloride extended release capsules usp are indicated for the treatment of panic disorder pd with or without agoraphobia efficacy was established in two 12 week placebo controlled trials http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00285 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#provenance http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#pubinfo http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig http://purl.org/nanopub/x/hasSignature jfJW9xt0gDKfNz7qNp/vO81l9cketKsri7eBSzpuz1bG3lUAUBc7fxebaQtPY0BuQIdlNqXnlUSB7fq+Cs/pzBvOZWg6ERQmSAfSYcgVqj9xpKX9LTK1Ln/k2nj+n9GxIKyrGeHw5rCxwyC+VMzrBGwXwHOAz4gro6uZsmrrni0= http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://purl.org/dc/terms/created 2021-06-29T08:11:52.392+02:00 http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAZdI_kAV38AtFAQoPj6u7-I12HWEPAtZcULfAmeezZOE https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs